Deverra Therapeutics

Deverra Therapeutics

Biotechnology Seattle, Washington, United States 11 employees
Employees
11
Contacts
1
Emails
1

Deverra Therapeutics Overview

Headquarters
Seattle, Washington, United States
Phone Number
Available in AeroLeads
Website
deverratx.com
Industry
Biotechnology
Employees
11
Founded
2020
Funding
3.5M
Company Email
Available in AeroLeads

About Deverra Therapeutics

Deverra Therapeutics is a clinical stage biotechnology company dedicated to the development of allogeneic, off-the-shelf cellular immunotherapies for on-demand treatment of patients with cancer and infectious diseases. The company has an exclusive license to a proprietary stem cell expansion and directed-differentiation platform from the Fred Hutchinson Cancer Research Center based on more than 20 years of federally funded research and data from 5 clinical trials. This platform can be used to generate a range of unmodified and modified immune cells to treat patients with cancer and infectious diseases.

Deverra Therapeutics Contact Details

People in AeroLeads
2
With contact data
1
Email contacts
1
50.0% coverage

Deverra Therapeutics Org Chart

Sample employees and titles
Name Title Contact
Anthony Y. Serial Entrepreneur / Early Stage Investor / Biotech / Proptech / Space / AI Tech / Sports / Media & Entertainment / Hospitality
View
Sean Mathew Operations Manager
Email

Employees by Management Level

Individual contributor 3 profiles
Manager 1 profile
Senior / Lead 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 2 2 1

Deverra Therapeutics Tech Stack

Data / AI 3 profiles

Compare Similar Companies to Deverra Therapeutics